CDSCO eases NOC norms to speed up clinical research and pharma exports (Soban News)

India’s drug regulator is withdrawing export NOC requirements for SRA markets and easing other low-risk approvals, even as it strengthens oversight of manufacturing quality​India’s drug regulator is withdrawing export NOC requirements for SRA markets and easing other low-risk approvals, even as it strengthens oversight of manufacturing quality ​Latest News [ SOBAN NEWS: International and National ]